![Michael Pellini](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Pellini
Direktor/Vorstandsmitglied bei
Coriell Institute for Medical Research
Profil
Michael J.
Pellini currently works at American Cancer Society, Inc., as Director-at-Large from 2023, Mission Hospital Foundation, as Director, Personalized Medicine Coalition, as Director, Octave Bioscience, Inc., as Director from 2018, Vineti, Inc., as Director, Twinstrand Biosciences, Inc., as Director, Cradle Genomics, Inc., as Director, Octave Health Group, Inc., as Director, Nusano, Inc., as Director, Go2 Foundation For Lung Cancer, as Director, Exai Bio, Inc., as Director, Thomas Jefferson University, as Member-President Leadership Council, Boston College, as Member-Technology Council, Coriell Institute for Medical Research, as Trustee, and Section 32 LLC, as Managing Partner from 2017.
Dr. Pellini also formerly worked at Genomics Collaborative, Inc., as President & Chief Executive Officer from 1999 to 2004, Foundation Medicine, Inc., as Chairman from 2017 to 2018, Adaptive Biotechnologies Corp., as Independent Director from 2018 to 2025, Acelerate, Inc., as Director, Cira Discovery Sciences, Inc., as Director, Tango Therapeutics Sub, Inc., as Director from 2018 to 2021, Sema4 OpCo, Inc., as Director from 2019 to 2021, Thrive Earlier Detection Corp., as Director, GeneDx Holdings Corp., as Independent Director from 2021 to 2023, Singular Genomics Systems, Inc., as Lead Independent Director from 2017 to 2025, Safeguard Scientifics, Inc., as Vice President-Life Sciences Group from 2007 to 2008, Clarient, Inc., as President & Chief Operating Officer from 2009 to 2011, Ben Franklin Technology Partners, as Investment Committee Member, and PLUS Diagnostics, Inc., as Chief Operating Officer & Executive Vice President from 2005 to 2006.
Dr. Pellini received his Masters Business Admin degree in 1992 from Drexel University, undergraduate degree in 1987 from Boston College, and doctorate degree from Sidney Kimmel Medical College.
Aktive Positionen von Michael Pellini
| Unternehmen | Position | Beginn |
|---|---|---|
Coriell Institute for Medical Research
 Coriell Institute for Medical Research Miscellaneous Commercial ServicesCommercial Services Operates as a human genome research organization | Direktor/Vorstandsmitglied | - |
Boston College
 Boston College Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Personalized Medicine Coalition
 Personalized Medicine Coalition Miscellaneous Commercial ServicesCommercial Services Engages in promoting the understanding and adoption of personalized medicine concepts, services and products | Direktor/Vorstandsmitglied | - |
Section 32 LLC
 Section 32 LLC Investment ManagersFinance Section 32 invests in companies located in the United States. The firm focuses on companies operating in the field of technology sector. It provides financing for early stage capital requirements. | Private Equity Investor | 01.12.2017 |
Octave Bioscience, Inc.
 Octave Bioscience, Inc. Medical/Nursing ServicesHealth Services Provides healthcare services | Direktor/Vorstandsmitglied | 12.07.2018 |
Vineti, Inc.
 Vineti, Inc. Medical/Nursing ServicesHealth Services Develops software for scaling and digital solutions for cell and gene therapies | Direktor/Vorstandsmitglied | - |
Mission Hospital Foundation | Direktor/Vorstandsmitglied | - |
Cradle Genomics, Inc.
 Cradle Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in researching and developing life sciences | Direktor/Vorstandsmitglied | - |
Nusano, Inc.
 Nusano, Inc. Medical SpecialtiesHealth Technology Manufactures medical radioisotope products | Direktor/Vorstandsmitglied | - |
| ░░░ ░░░░░░░░░░ ░░░ ░░░░ ░░░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
Ehemalige bekannte Positionen von Michael Pellini
| Unternehmen | Position | Ende |
|---|---|---|
| ░░░░░░░░ ░░░░░░░░░░░░░░░ ░░░░░░░░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░ ░░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Michael Pellini
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
76
Beziehungen ersten Grades
30
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 30 |
|---|---|
Safeguard Scientifics, Inc.
 Safeguard Scientifics, Inc. Investment ManagersFinance Invests in technology companies | Finance |
Clarient, Inc.
 Clarient, Inc. Medical/Nursing ServicesHealth Services Provides cancer diagnostic testing services | Health Services |
Thomas Jefferson University
 Thomas Jefferson University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Acelerate, Inc.
 Acelerate, Inc. BiotechnologyHealth Technology Provides systems cell biology solutions | Health Technology |
Genomics Collaborative, Inc.
 Genomics Collaborative, Inc. Medical SpecialtiesHealth Technology Provides clinical samples and the application of human genetics to target validation for drug discovery | Health Technology |
Boston College
Boston College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
American Cancer Society, Inc.
 American Cancer Society, Inc. Miscellaneous Commercial ServicesCommercial Services Operates voluntary health organization for cancer research | Commercial Services |
Ben Franklin Technology Partners /Ventures/
 Ben Franklin Technology Partners /Ventures/ Investment ManagersFinance Ben Franklin Tech Partners invests in companies located in the US. The firm focuses on IT, life sciences and physical sciences. It participates in seed and early-stage capital requirements. | Finance |
PLUS Diagnostics, Inc.
 PLUS Diagnostics, Inc. Medical/Nursing ServicesHealth Services Provides anatomic pathology services | Health Services |
Mission Hospital Foundation | |
Cira Discovery Sciences, Inc.
 Cira Discovery Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Develops pattern discovery algorithms for genomic and other life sciences studies | Commercial Services |
Coriell Institute for Medical Research
Coriell Institute for Medical Research Miscellaneous Commercial ServicesCommercial Services Operates as a human genome research organization | Commercial Services |
Personalized Medicine Coalition
Personalized Medicine Coalition Miscellaneous Commercial ServicesCommercial Services Engages in promoting the understanding and adoption of personalized medicine concepts, services and products | Commercial Services |
Foundation Medicine, Inc.
 Foundation Medicine, Inc. Medical/Nursing ServicesHealth Services Provides diagnostic solutions for cancer care | Health Services |
Lebow College of Business
 Lebow College of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Adaptive Biotechnologies Corp.
 Adaptive Biotechnologies Corp. BiotechnologyHealth Technology Develops minimal residual disease and immune medicine | Health Technology |
Octave Bioscience, Inc.
Octave Bioscience, Inc. Medical/Nursing ServicesHealth Services Provides healthcare services | Health Services |
Vineti, Inc.
Vineti, Inc. Medical/Nursing ServicesHealth Services Develops software for scaling and digital solutions for cell and gene therapies | Health Services |
Twinstrand Biosciences, Inc.
 Twinstrand Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Develops genomic technology and duplex sequencing technology to applications in clinical medicine & life sciences | Commercial Services |
Tango Therapeutics Sub, Inc.
 Tango Therapeutics Sub, Inc. BiotechnologyHealth Technology Develops transformational new drugs for cancer patients | Health Technology |
Section 32 LLC
Section 32 LLC Investment ManagersFinance Section 32 invests in companies located in the United States. The firm focuses on companies operating in the field of technology sector. It provides financing for early stage capital requirements. | Finance |
Singular Genomics Systems, Inc.
 Singular Genomics Systems, Inc. Miscellaneous Commercial ServicesCommercial Services Develops scalable spatial multiomics technology for precision diagnostics and personalized medicine | Commercial Services |
Mount Sinai Genomics, Inc.
 Mount Sinai Genomics, Inc. Medical/Nursing ServicesHealth Services Operates online predictive health analysis platform for diagnosis, treatment and prevention of diseases | Health Services |
Thrive Earlier Detection Corp.
 Thrive Earlier Detection Corp. Medical SpecialtiesHealth Technology Develops liquid biopsy test that is designed to detect cancers at early stages | Health Technology |
Cradle Genomics, Inc.
Cradle Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in researching and developing life sciences | Commercial Services |
Octave Health Group, Inc.
 Octave Health Group, Inc. Medical/Nursing ServicesHealth Services Provides online therapy services | Health Services |
GeneDx Holdings Corp.
 GeneDx Holdings Corp. Medical/Nursing ServicesHealth Services Provides diagnostic genetic testing services | Health Services |
Nusano, Inc.
Nusano, Inc. Medical SpecialtiesHealth Technology Manufactures medical radioisotope products | Health Technology |
Go2 Foundation For Lung Cancer
 Go2 Foundation For Lung Cancer Go2 Foundation For Lung Cancer is a national nonprofit organization focused on confronting lung cancer through education, support, advocacy, and research. The private company is based in Washington, DC. The foundation provides resources on lung cancer types, risk factors, symptoms, diagnosis, staging, and treatment options such as surgery, chemotherapy, radiation, targeted therapy, immunotherapy, biomarker testing, and clinical trials. It promotes early detection through lung cancer screening with low-dose CT scans and supports a national network of centers of excellence for lung cancer care. The organization offers personalized assistance via a free helpline, peer support programs, online social groups, coping skills workshops, and educational events. Go2 Foundation advances lung cancer research through initiatives like the lung cancer registry and partnerships with research institutes, and advocates for increased research funding, improved healthcare access, and reduced stigma. Community engagement is encouraged through fundraising, advocacy campaigns, awareness events, and sharing personal stories. Educational materials are provided in multiple formats and languages. The CEO of the company is Laurie Fenton Ambrose. | |
Exai Bio, Inc.
 Exai Bio, Inc. Packaged SoftwareTechnology Services Develops a ribonucleic acid-based liquid biopsy platform for early cancer detection | Technology Services |
